Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

660 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Increased microvascular density predicts relapse in Wilms' tumor.
Abramson LP, Grundy PE, Rademaker AW, Helenowski I, Cornwell M, Katzenstein HM, Reynolds M, Arensman RM, Crawford SE. Abramson LP, et al. J Pediatr Surg. 2003 Mar;38(3):325-30; discussion 325-30. doi: 10.1053/jpsu.2003.50102. J Pediatr Surg. 2003. PMID: 12632343
Phase I study of alpelisib (BYL-719) and trastuzumab emtansine (T-DM1) in HER2-positive metastatic breast cancer (MBC) after trastuzumab and taxane therapy.
Jain S, Shah AN, Santa-Maria CA, Siziopikou K, Rademaker A, Helenowski I, Cristofanilli M, Gradishar WJ. Jain S, et al. Among authors: rademaker a. Breast Cancer Res Treat. 2018 Sep;171(2):371-381. doi: 10.1007/s10549-018-4792-0. Epub 2018 May 30. Breast Cancer Res Treat. 2018. PMID: 29850984 Clinical Trial.
Phase II study of pembrolizumab and capecitabine for triple negative and hormone receptor-positive, HER2-negative endocrine-refractory metastatic breast cancer.
Shah AN, Flaum L, Helenowski I, Santa-Maria CA, Jain S, Rademaker A, Nelson V, Tsarwhas D, Cristofanilli M, Gradishar W. Shah AN, et al. Among authors: rademaker a. J Immunother Cancer. 2020 Feb;8(1):e000173. doi: 10.1136/jitc-2019-000173. J Immunother Cancer. 2020. PMID: 32060053 Free PMC article. Clinical Trial.
660 results